Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,767 | 118 | 98.2% |
| Education | $49.90 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $549.22 | 26 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $486.39 | 36 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $289.21 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $261.27 | 3 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $185.88 | 6 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $163.79 | 4 | $0 (2024) |
| PFIZER INC. | $116.51 | 7 | $0 (2021) |
| Amgen Inc. | $105.63 | 5 | $0 (2022) |
| Medtronic Vascular, Inc. | $93.02 | 1 | $0 (2017) |
| Covidien LP | $91.59 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $283.24 | 10 | Regeneron Healthcare Solutions, Inc. ($163.79) |
| 2023 | $181.31 | 8 | Sun Pharmaceutical Industries Inc. ($73.06) |
| 2022 | $303.46 | 13 | Janssen Pharmaceuticals, Inc ($99.28) |
| 2021 | $386.32 | 24 | Janssen Pharmaceuticals, Inc ($154.43) |
| 2020 | $62.06 | 3 | Janssen Pharmaceuticals, Inc ($46.55) |
| 2019 | $664.79 | 20 | Gilead Sciences, Inc. ($292.45) |
| 2018 | $457.41 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($246.23) |
| 2017 | $478.33 | 31 | Janssen Pharmaceuticals, Inc ($151.16) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $118.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/05/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Oncology | ||||||
| 02/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Diagnostics | ||||||
| 10/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $38.33 | General |
| Category: Ophthalmology | ||||||
| 09/18/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: Ophthalmology | ||||||
| 09/18/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Respiratory | ||||||
| 05/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.12 | General |
| 03/14/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Gastroenterology | ||||||
| 11/14/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $37.72 | General |
| Category: Ophthalmology | ||||||
| 11/04/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Bone Health | ||||||
| 10/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: Ophthalmology | ||||||
| 05/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.97 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 262 | 418 | $40,771 | $19,478 |
| 2022 | 7 | 280 | 460 | $47,975 | $22,333 |
| 2021 | 6 | 237 | 402 | $41,486 | $18,751 |
| 2020 | 7 | 199 | 320 | $42,648 | $15,439 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 142 | $24,681 | $11,139 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 62 | $7,557 | $3,111 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $3,892 | $2,807 | 72.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 73 | 144 | $2,880 | $1,210 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $656.00 | $467.88 | 71.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $552.96 | $371.88 | 67.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $552.96 | $371.88 | 67.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 190 | $32,372 | $14,644 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 57 | $6,947 | $3,021 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $3,308 | $2,444 | 73.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $1,056 | $794.16 | 75.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $760.00 | $718.49 | 94.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 85 | 148 | $2,960 | $437.76 | 14.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 13 | 13 | $572.00 | $274.17 | 47.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 175 | $30,405 | $13,757 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $3,308 | $2,493 | 75.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 26 | $3,047 | $1,222 | 40.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 23 | 23 | $1,023 | $472.19 | 46.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 82 | 141 | $2,820 | $423.00 | 15.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $884.00 | $383.80 | 43.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 70 | 177 | $30,583 | $11,120 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 18 | 18 | $3,502 | $2,318 | 66.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 19 | $2,316 | $732.45 | 31.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 21 | 22 | $814.00 | $430.76 | 52.9% |
| 99423 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | Office | 2020 | 20 | 20 | $3,825 | $423.84 | 11.1% |
About Dr. Mai Phan, M.D
Dr. Mai Phan, M.D is a Internal Medicine healthcare provider based in Reseda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306879283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mai Phan, M.D has received a total of $2,817 in payments from pharmaceutical and medical device companies, with $283.24 received in 2024. These payments were reported across 122 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,767).
As a Medicare-enrolled provider, Phan has provided services to 978 Medicare beneficiaries, totaling 1,600 services with total Medicare billing of $76,001. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Reseda, CA
- Active Since 07/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306879283
Products in Payments
- XARELTO (Drug) $336.42
- FARXIGA (Drug) $227.96
- Vemlidy (Drug) $203.85
- Cequa (Drug) $185.88
- DUPIXENT (Biological) $163.79
- JARDIANCE (Drug) $122.39
- INVOKANA (Drug) $108.09
- CoreValve Evolut (Device) $93.02
- LigaSure (Device) $91.59
- VRAYLAR (Drug) $73.51
- LYRICA (Drug) $58.18
- Prolia (Biological) $54.37
- XIIDRA (Drug) $47.55
- INVOKAMET (Drug) $41.88
- TOUJEO (Drug) $38.54
- BREZTRI (Drug) $32.80
- APTIMA (Device) $32.52
- Ozempic (Drug) $30.46
- OXERVATE (Drug) $29.99
- STEGLATRO (Drug) $27.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Reseda
Dr. Leo Polosajian, M.d, M.D
Internal Medicine — Payments: $191,898
Dr. Ilya Rachman, M.d, M.D
Internal Medicine — Payments: $11,074
Mr. Marvin Pietruszka, M.d, M.D
Internal Medicine — Payments: $5,667
Eyal Shtorch, Md, MD
Internal Medicine — Payments: $1,382
Vartan Papazian, D.o, D.O
Internal Medicine — Payments: $935.98
Jose Martinez Cardenas, M.d, M.D
Internal Medicine — Payments: $761.81